CLASS II ONGOING Drug recall · Reported 10 Jan 2024 · FDA Enforcement Report

Nasal Spray Original No Drip Oxymetazoline HCl Nasal recalled

Seaway Pharma is recalling Nasal Spray Original No Drip Oxymetazoline HCl Nasal Solution, 12 Hour Pump Mist, a), distributed in Michigan, Pennsylvania. The recall was initiated on 28 Dec 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # SD23032, Exp 04/30/2026
NDC63868-607
UPC0635515988446, 635515988439, 840986035098
Quantity recalled7,992 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0214-2024
FDA event ID
93708
Recalling firm
Seaway Pharma, Massena, NY
Manufacturer
CHAIN DRUG MARKETING ASSOCIATION INC.
Classification
Class II
Status
Ongoing
Recall initiated
28 Dec 2023
FDA classified
4 Jan 2024
Reported
10 Jan 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility
Drug class
Nasal Sprays

Timeline

28 Dec 2023Recall initiated by company
4 Jan 2024Classified by FDA+7 days
10 Jan 2024Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Nasal Spray Original No Drip Oxymetazoline HCl Nasal Solution, 12 Hour Pump Mist, 1 FL oz. (30 mL) bottle, a) Quality Choice, Distributed by C.D.M.A. Inc., 43157 W 9 Mile Rd, Novi, MI 48375, NDC# 63868-607-01, UPC 6-35515-98843-9, b) Premier Value, Distributed by: Pharmacy Value Alliance, LLC, 407 East Lancaster Avenue, Wayne, PA 19087 UPC 8-40986-03509-8.

Where it was distributed

MI, PA

MichiganPennsylvania

Questions about this recall

Why was it recalled?

CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.

Which lots are affected?

Lot # SD23032, Exp 04/30/2026

Where was it sold?

MI, PA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

3 other products · FDA event 93708

This product is part of a recall event; the main page for the event is Quality Choice No Drip Extra Moisturizing Nasal Pump Mist recalled.

More recalls from Seaway Pharma

All 4
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIPremier Value Tussin Cough DM recalled by Seaway PharmaSeaway PharmaSterilityMI, PA
DrugCLASS IIQuality Choice No Drip Severe Congestion Nasal Pump Mist recalledOxymetazoline HydrochlorideSeaway PharmaSterilityMI, PA
DrugCLASS IIQuality Choice No Drip Extra Moisturizing Nasal Pump Mist recalledOxymetazoline HydrochlorideSeaway PharmaSterilityMI, PA

Other Oxymetazoline recalls

All 27